The US Bankruptcy Court approved the second amended disclosure statement of Insys Therapeutics, Inc. on December 4, 2019. The debtor had filed its second amended disclosure statement in the Court on November 29, 2019. November 25, 2019 has been fixed as voting record date. The deadline to vote on the plan is January 6, 2020 and the plan objection deadline is January 6, 2020. The confirmation hearing for the plan has been scheduled for January 16-17, 2020.